Journal of Clinical and Aesthetic Dermatology

JUN 2017

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link:

Contents of this Issue


Page 22 of 63

23 JCAD journal of clinical and aesthetic dermatology June 2017 • Volume 10 • Number 6 my face" burned because of rosacea, with 29.8 percent in the PPR cohort and 13.2 percent in the ETR cohort reporting that "a little of my face," "some of my face," "quite a bit of my face," or "a lot of my face" burned because of rosacea (p<0.001). In both cohorts, facial redness occurred predominantly in the cheeks, followed by the nose. While most of the participants in the PPR cohort reported having "a few" or "some" facial bumps or pimples, only 11.5 percent reported having more than a few bumps or pimples with pus. The main locations of bumps and pimples were the cheeks, forehead, nose, and chin. Coping and avoidance behaviors. The majority of participants in both the ETR and PPR cohorts indicated that they practiced stress and/or anxiety management and used makeup to cover rosacea, and at least half of participants in each cohort reported that they changed their exercise regimens to cope with rosacea flare-ups (Figure 3A). The majority of all participants also avoided sun exposure, hot baths and/or saunas, certain skin care products, hot beverages, and alcohol (Figure 3B). Significantly more subjects in the PPR cohort avoided specific skin care products than did those in the ETR cohort (p=0.0011). This was also true of avoiding specific foods (p=0.0073). Rosacea treatment. In the ETR and PPR cohorts, respectively, 20.3 percent and 24.1 percent reported having seen a healthcare provider for the assessment and/or treatment of rosacea during the preceding three months. For those participants reporting such visits to one or more providers, 76.7 percent had seen a dermatologist, 32.6 percent had gone to their primary care physician, 10.9 percent had seen a nurse practitioner or physician's assistant, and 15.5 percent had talked with a pharmacist. Treatment utilization patterns for topical and oral prescription agents did not differ significantly between the ETR and PPR cohorts (Table 3). More than half (55.7%) of the participants had used a prescribed topical agent for rosacea in the preceding month, and 26.3 percent had used a prescribed oral antibiotic. Metronidazole was the most commonly used topical agent, O R I G I N A L R E S E A R C h Figure 2A. Initial symptoms reported by study participants. ‡p<0.0001 ETR=erythematotelangiectatic rosacea; PPR=papulopustular rosacea

Articles in this issue

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - JUN 2017